短足软珊瑚Cladiella latissima中二萜化合物研究

软珊瑚是热带和亚热带海洋中常见的海洋腔肠动物,对其化学成分及生理活性研究发现软珊瑚中主要含有结构新颖的倍半萜、二萜和多羟基甾醇等化合物,个别软珊瑚中含有自然界罕见的双大环四萜类化合物.本文报道对采自广西北海的短足软珊瑚(Cladiella latissima)中的二萜化合物的研究.     

南海红树林内生真菌Cephalosporium sp．（2090#）次级代谢产物研究

海洋微生物是寻找海洋药物先导化合物的一个新的源泉,人们已经从海洋微生物的次级代谢产物中分离得到了很多结构新颖或强药理活性的化合物[1]。我们在对中国南海红树林内生真菌的研究中,发现了大量的生物活性化合物,这也揭示了我国南海海洋真菌具有极大的药用开发前景[2-5]。红     

红树林真菌Penicillium sp．No．ZZF33发酵液化学成分的研究

海洋微生物是寻找药物先导化合物的一个新的源泉,人类已从海洋微生物的次级代谢产物中发现了许多有生物活性的结构新颖的化合物[1]。近几年,本研究组对来自南中国海红树林的海洋真菌的代谢产物进行了系统的研究,从中发现大量有生物活性的化合物,揭示了红树林真菌的巨大应用潜力     

海洋天然产物化学的进展

海洋天然产物化学是化学和生物学的边缘学科,是天然有机化学的重要领域。占地球总面积71％的海洋中有极其丰富的食物、药物和工业原料,有着许多陆地上没有的奇异结构的化合物,有大量吸引人们去研究探索的有趣课     

海洋放线菌S592次级代谢产物及其体外抑菌活性研究

对海洋放线菌S592的次级代谢产物以及体外抑菌活性进行研究.将菌株S592进行大量发酵,采用色谱方法对菌株发酵产物进行分离纯化,通过波谱技术对所获单体化合物进行结构鉴定,并测定化合物的体外抑菌活性.从海洋放线菌S592中分离得到6个化合物,含2个螺环抗生素lobophorin类化合物,1个环肽类化合物,2个苯甲酰胺类化...     

海洋天然产物研究新进展

海洋天然产物化学是目前天然产物化学中最活跃的研究领域之一。近年来,从海洋生物中分离到非常多的化学结构和生理活性上令人注目的新化合物,引起了有机化学家和药物化学家的关注。本文按萜类、太环内酯、聚醚类、生物碱,环肽、含氰化合物、甾醇、聚丙酸酯类化合物等化学结构来概述海洋天然产物研究近年来的进展。     

两种南海海洋真菌2508代谢产物的DNA活性研究

研究了从南海海洋真菌2508号分离得到的一种新的海洋代谢产物Xylopyridine A (1)和一个已知代谢产物xylopyrazine A (2).他们的结构由光谱数据确定。同时通过荧光淬灭实验和光谱滴定实验研究了两种化合物与DNA的结合。结果表面1显示出很强的DNA结合作用并且是通过扦插结合的,可开发用于强DNA结合剂方面的用途。     

海洋珊瑚中抗肿瘤活性物质及其提取、分离方法

珊瑚主要生长在热带、亚热带海洋中，资源非常丰富且具有显著的生物多样性。研究表明，海洋珊瑚中含有许多结构多样、生理活性独特的次生代谢产物。本文概要地介绍了从珊瑚中发现的具有抗肿瘤活性的各种萜类和甾类化合物的来源、结构、抗肿瘤活性和提取、分离方法，同时展望了海洋药物的研究与开发前景。     

光学活性取代双环[3,3,0]辛酮的不对称合成研究

在复杂天然产物的手性合成中,对映选择构筑不对称季碳是有机合成工作者面临的挑战之一。海洋天然产物(一)-△~(9(12))-Capnellene是一族具有非线性三环结构的倍半萜类化合物。自70年代中期从软珊瑚中分离鉴定出这类化合物后,开始的合成研究足以表明有机合成家们对此类化合物的兴趣。就我们所知,人     

吲哚衍生物的合成及其海洋防污性能

以吲哚和酰氯(苯甲酰氯及苯磺酰氯)为原料，合成了7个N-酰基取代吲哚类化合物(a~g)，其结构经¹H NMR和元素分析确证。研究了化合物对球等鞭金藻、亚心形扁藻和舟形藻以及藤壶幼虫的生长抑制活性。结果表明：当吲哚结构连接电负性较高的基团时，化合物对藻类和藤壶幼虫的生长抑制性较好，其中以连接苯磺酰基化合物的抑制效果最佳。目标化合物对藤壶幼虫12 h和24 h的半致死浓度(LC₅₀)明显低于底物吲哚，其中以苯磺酰基取代的化合物最低。采用目标化合物制备的海洋防污涂料，浅海挂板90 d后，对海洋污损生物的附着表现出明显的抑制作用。     

Monitoring organic microcontaminants in the marine environment: principles, programmes and progress

Monitoring trace organic microcontaminants in the marine environment has been on-going for several decades. However, the compounds considered in most programmes are still mainly the ‘old’ organochlorines, the polynuclear aromatic hydrocarbons, several metals and metal-containing compounds. However, the marine environment is threatened by a much larger suite of organic microcontaminants. In recent years, European and other international organisations have been moving towards extending their lists of priority hazardous substances. Simultaneously, there have become available novel analytical techniques that offer new possibilities for monitoring in the marine environment.     

Chemical Diversity and Biological Activity of Secondary Metabolites Isolated from Indonesian Marine Invertebrates

Marine invertebrates have been reported to be an excellent resource of many novel bioactive compounds. Studies reported that Indonesia has remarkable yet underexplored marine natural products, with a high chemical diversity and a broad spectrum of biological activities. This review discusses recent updates on the exploration of marine natural products from Indonesian marine invertebrates (i.e., sponges, tunicates, and soft corals) throughout 2007–2020. This paper summarizes the structural diversity and biological function of the bioactive compounds isolated from Indonesian marine invertebrates as antimicrobial, antifungal, anticancer, and antiviral, while also presenting the opportunity for further investigation of novel compounds derived from Indonesian marine invertebrates.     

Novel Marine Secondary Metabolites Worthy of Development as Anticancer Agents: A Review

Secondary metabolites from marine sources have a wide range of biological activity. Marine natural products are promising candidates for lead pharmacological compounds to treat diseases that plague humans, including cancer. Cancer is a life-threatening disorder that has been difficult to overcome. It is a long-term illness that affects both young and old people. In recent years, significant attempts have been made to identify new anticancer drugs, as the existing drugs have been useless due to resistance of the malignant cells. Natural products derived from marine sources have been tested for their anticancer activity using a variety of cancer cell lines derived from humans and other sources, some of which have already been approved for clinical use, while some others are still being tested. These compounds can assault cancer cells via a variety of mechanisms, but certain cancer cells are resistant to them. As a result, the goal of this review was to look into the anticancer potential of marine natural products or their derivatives that were isolated from January 2019 to March 2020, in cancer cell lines, with a focus on the class and type of isolated compounds, source and location of isolation, cancer cell line type, and potency (IC₅₀ values) of the isolated compounds that could be a guide for drug development.     

Secondary Metabolites from Marine Sources with Potential Use as Leads for Anticancer Applications

The development of novel anticancer agents is essential to finding new ways to treat this disease, one of the deadliest diseases. Some marine organisms have proved to be important producers of chemically active compounds with valuable bioactive properties, including anticancer. Thus, the ocean has proved to be a huge source of bioactive compounds, making the discovery and study of these compounds a growing area. In the last few years, several compounds of marine origin, which include algae, corals, and sea urchins, have been isolated, studied, and demonstrated to possess anticancer properties. These compounds, mainly from securamines and sterols families, have been tested for cytotoxic/antiproliferative activity in different cell lines. Bioactive compounds isolated from marine organisms in the past 5 years that have shown anticancer activity, emphasizing the ones that showed the highest cytotoxic activity, such as securamines H and I, cholest-3β,5α,6β-triol, (E)-24-methylcholest-22-ene-3β,5α,6β-triol, 24-methylenecholesta-3β,5α,6β-triol, and 24-methylcholesta-3β,5α,6β-triol, will be discussed in this review. These studies reveal the possibility of new compounds of marine origin being used as new therapeutic agents or as a source of inspiration to develop new therapeutic agents.     

海洋环境中的天然溴代有机物

近些年来,环境中的溴代有机污染物逐渐成为人们关注的热点。最近的研究发现,海洋环境中的一些溴代有机物并非来自于人为污染,而是来自于天然合成。海洋环境中存在的这些天然溴代有机物引起了人们极大的兴趣。这些天然溴代有机物在海洋生物、底泥、海水以及大气中广泛存在,并可在海洋哺乳动物体内富集。毒理学研究表明,一些天然溴代有机物具有一定的生物活性与毒性。因此,深入研究天然溴代有机物的环境分布与环境影响具有重要的意义。本文介绍了代表性天然溴代有机物的环境分布、毒性及其可能的来源,并对其未来研究方向和趋势作了展望。     

Bioactive Metabolites from Marine Algae as Potent Pharmacophores against Oxidative Stress-Associated Human Diseases: A Comprehensive Review

In addition to cancer and diabetes, inflammatory and ROS-related diseases represent one of the major health problems worldwide. Currently, several synthetic drugs are used to reduce oxidative stress; nevertheless, these approaches often have side effects. Therefore, to overcome these issues, the search for alternative therapies has gained importance in recent times. Natural bioactive compounds have represented, and they still do, an important source of drugs with high therapeutic efficacy. In the “synthetic” era, terrestrial and aquatic photosynthetic organisms have been shown to be an essential source of natural compounds, some of which might play a leading role in pharmaceutical drug development. Marine organisms constitute nearly half of the worldwide biodiversity. In the marine environment, algae, seaweeds, and seagrasses are the first reported sources of marine natural products for discovering novel pharmacophores. The algal bioactive compounds are a potential source of novel antioxidant and anticancer (through modulation of the cell cycle, metastasis, and apoptosis) compounds. Secondary metabolites in marine Algae, such as phenolic acids, flavonoids, and tannins, could have great therapeutic implications against several diseases. In this context, this review focuses on the diversity of functional compounds extracted from algae and their potential beneficial effects in fighting cancer, diabetes, and inflammatory diseases.     

The role of vanadium bromoperoxidase in the biosynthesis of halogenated marine natural products

Halogenated natural products are frequently reported metabolites in marine seaweeds. These compounds span a range from halogenated indoles, terpenes, acetogenins, phenols, etc., to volatile halogenated hydrocarbons that are produced on a very large scale. In many cases these halogenated marine metabolites possess biological activities of pharmacological interest. Given the abundance of halogenated marine natural products found in marine organisms and their potentially important biological activities, the biogenesis of these compounds has intrigued marine natural product chemists for decades. Over a quarter of a century ago, a possible role for haloperoxidase enzymes was first suggested in the biogenesis of certain halogenated marine natural products, although this was long before haloperoxidases were discovered in marine organisms. Since that time, FeHeme- and Vanadium-haloperoxidases (V-HPO) have been discovered in many marine organisms. The structure and catalytic activity of vanadium haloperoxidases is reviewed herein, including the importance of V-HPO-catalyzed bromination and cyclization of terpene substrates.     

海洋溴吡咯生物碱的研究进展

大量的溴吡咯生物碱从海绵中得到分离, 并表现出良好的生理活性. 这类化合物因其结构的新颖性、多样性、以及良好的生理活性而成为合成化学家关注的焦点. 综述了近年来海洋溴吡咯生物碱的分离和合成进展.     

Perthamides C and D, two new potent anti-inflammatory cyclopeptides from a Solomon Lithistid sponge Theonella swinhoei

Two new metabolites, perthamides C and D, have been isolated from the marine sponge Theonella swinhoei. Their structures were determined by interpretation of NMR and ESIMS data. All compounds exhibited in vivo potent anti-inflammatory activity. Biological activity and structural elucidation are reported.     

Marine natural products

This review covers the literature published in 2002 for marine natural products, with 579 citations (413 for the period January to December 2002) referring to compounds isolated from marine microorganisms and phytoplankton, green algae, brown algae, red algae, sponges, coelenterates, bryozoans, molluscs, tunicates and echinoderms. The emphasis is on new compounds (677 for 2002), together with their relevant biological activities, source organisms and country of origin. Syntheses that lead to the revision of structures or stereochemistries have been included (114), including any first total syntheses of a marine natural product.